ANTI-IGE-ANTIKÖRPER

Patent europeic · EP3468995 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3468995
Numer da la dumonda
EP17731090
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
08-06-2017
Publitgà
17-04-2019
Concedì
23-09-2026
La protecziun finescha il pli tard
07-06-2037
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 16/28 (2006.01)
C07K 14/735 (2006.01)
C07K 16/42 (2006.01)
Prioritad
GB 201610198 10.06.2016
GB 201702435 15.02.2017
Dumonda PCT
PCT/EP2017/063916 08.06.2017
Publicaziun PCT
WO2017/211928 14.12.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.09.2026

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventur

ADAMS, Ralph

Slough Berkshire SL1 3WE, GB

CESKA, Thomas Allen

Slough Berkshire SL1 3WE, GB

DAVIES, Anna Marie

London SE1 1UL, GB

HENRY, Alistair James

Slough Berkshire SL1 3WE, GB

LIU, Xiaofeng

Slough Berkshire SL1 3WE, GB

MCDONNELL, James Michael

London SE1 1UL, GB

SUTTON, Brian John

London SE1 1UL, GB

WESTWOOD, Marta Katarzyna

Slough Berkshire SL1 3WE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.